We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
Turnover
4.07%
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$6.18T
AUM Growth
+$647B
(+12%)
Cap. Flow
+$78.1B
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
28.81%
Holding
4,383
New
103
Increased
2,425
Reduced
1,410
Closed
108
Avg Time Held
8.1
years
Top 10 Avg Time Held
4.8
years
Top 20 Avg Time Held
6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.95B |
| 2 |
NVIDIA
NVDA
|
+$4.97B |
| 3 |
Capital One
COF
|
+$4.5B |
| 4 |
Amazon
AMZN
|
+$3.45B |
| 5 |
Flutter Entertainment
FLUT
|
+$3.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Discover Financial Services
DFS
|
+$5.32B |
| 2 |
Intra-Cellular Therapies Inc.
ITCI
|
+$1.26B |
| 3 |
Amphenol
APH
|
+$1.18B |
| 4 |
Welltower
WELL
|
+$987M |
| 5 |
US Steel
X
|
+$825M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.14% |
| 2 | Financials | 14% |
| 3 | Consumer Discretionary | 10.14% |
| 4 | Healthcare | 9.38% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3526
MAIA Biotechnology
MAIA
$69.8M
| $2.05M | ﹤0.01% |
1,140,769
+490,513
| +75% | +$878K |
2023 Q2
8 quarters
|
|
3527
iShares MSCI USA Min Vol Factor ETF
USMV
$24B
| $2.05M | ﹤0.01% |
21,850
+31
| +0.1% | +$2.85K |
2023 Q1
9 quarters
|
|
3528
Manhattan Bridge Capital
LOAN
$39.4M
| $2.05M | ﹤0.01% |
374,055
+3,351
| +0.9% | +$17.4K |
2014 Q3
43 quarters
|
|
3529
INNOVATE Corp
VATE
$83.8M
| $2.03M | ﹤0.01% |
394,681
-5,913
| -1% | -$35.4K |
2015 Q1
41 quarters
|
|
3530
NetSol Technologies
NTWK
$77.6M
| $2.02M | ﹤0.01% |
649,497
| – | – |
2013 Q2
48 quarters
|
|
3531
Outlook Therapeutics
OTLK
$121M
| $2M | ﹤0.01% |
1,251,598
+414,191
| +49% | +$660K |
2016 Q3
35 quarters
|
|
3532
Children's Place
PLCE
$25.4M
| $2M | ﹤0.01% |
451,675
+78,817
| +21% | +$444K |
2013 Q2
48 quarters
|
|
3533
Adicet Bio
ACET
$47.4M
| $2M | ﹤0.01% |
204,533
+4,165
| +2% | +$43.9K |
2018 Q1
29 quarters
|
|
3534
Caledonia Mining Corp
CMCL
$457M
| $1.99M | ﹤0.01% |
102,775
+6,242
| +6% | +$97.7K |
2023 Q2
8 quarters
|
|
3535
Rezolve AI
RZLV
$746M
| $1.98M | ﹤0.01% |
+643,018
| New | +$1.27M |
2025 Q2
0 quarters
|
|
3536
Culp Inc
CULP
$48M
| $1.97M | ﹤0.01% |
502,043
-10,134
| -2% | -$40.7K |
2013 Q2
48 quarters
|
|
3537
Acumen Pharmaceuticals
ABOS
$122M
| $1.96M | ﹤0.01% |
1,689,351
-247,640
| -13% | -$266K |
2021 Q3
15 quarters
|
|
3538
INmune Bio
INMB
$46.1M
| $1.96M | ﹤0.01% |
847,751
+21,138
| +3% | +$155K |
2020 Q3
19 quarters
|
|
3539
Broadwind
BWEN
$82.1M
| $1.96M | ﹤0.01% |
1,081,459
+112,994
| +12% | +$191K |
2013 Q2
48 quarters
|
|
3540
Surrozen
SRZN
$293M
| $1.96M | ﹤0.01% |
218,950
+150,924
| +222% | +$1.38M |
2021 Q3
15 quarters
|
|
3541
SurgePays
SURG
$6.65M
| $1.94M | ﹤0.01% |
621,614
+42,735
| +7% | +$118K |
2021 Q4
14 quarters
|
|
3542
Auburn National Bancorp
AUBN
$92.2M
| $1.93M | ﹤0.01% |
74,683
+200
| +0.3% | +$4.19K |
2018 Q2
28 quarters
|
|
3543
iShares MSCI China ETF
MCHI
$5.9B
| $1.93M | ﹤0.01% |
35,055
-16,000
| -31% | -$849K |
2023 Q2
8 quarters
|
|
3544
Actinium Pharmaceuticals
ATNM
$32.7M
| $1.92M | ﹤0.01% |
1,371,840
-199,924
| -13% | -$299K |
2014 Q2
44 quarters
|
|
3545
Purple Innovation
PRPL
$9.72M
| $1.92M | ﹤0.01% |
105,244
-13,375
| -11% | -$246K |
2018 Q2
28 quarters
|
|
3546
Ramaco Resources Class B
METCB
$258M
| $1.91M | ﹤0.01% |
252,728
+17,057
| +7% | +$124K |
2023 Q2
8 quarters
|
|
3547
DELISTED
Mural Oncology
MURA
| $1.91M | ﹤0.01% |
772,851
-11,224
| -1% | -$26.5K |
2023 Q4
6 quarters
|
|
3548
State Street SPDR S&P Dividend ETF
SDY
$21.4B
| $1.91M | ﹤0.01% |
14,060
+700
| +5% | +$92.8K |
2023 Q1
9 quarters
|
|
3549
DELISTED
Adverum Biotechnologies
ADVM
| $1.9M | ﹤0.01% |
883,937
-145,389
| -14% | -$407K |
2014 Q3
43 quarters
|
|
3550
Franklin Wireless
FKWL
| $1.9M | ﹤0.01% |
453,594
+237,800
| +110% | +$1.08M |
2021 Q2
16 quarters
|
|
Similar funds
Vanguard Group's Q2 2025 Portfolio in Review
As of Q2 2025, Vanguard Group held 4,383 positions worth $6.18T, up 12% from $5.53T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q2 2025: portfolio turnover was 4.8%. Vanguard Group opened 103 new positions and exited 108, leaving the 4,383-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q2 2025 buy was Amrize Ltd: 21,350,540 shares worth $1.07B.
- Vanguard Group added most to Microsoft in Q2 2025, an estimated $5.95B increase.
- Vanguard Group's biggest Q2 2025 reduction was Amphenol, cutting an estimated $1.18B.
- Vanguard Group fully exited Discover Financial Services in Q2 2025, selling an estimated $5.32B.
- Vanguard Group's ten largest holdings make up 29% of its $6.18T portfolio in Q2 2025.
- Vanguard Group opened 103 new positions and closed 108 in Q2 2025.
- Vanguard Group's portfolio value rose 12% quarter-over-quarter to $6.18T.
Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.